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Bilayer thickness determines the alignment of
model polyproline helices in lipid membranes†
Vladimir Kubyshkin, *ab Stephan L. Grage, c Anne S. Ulrich cd and
Nediljko Budisa ab
Our understanding of protein folds relies fundamentally on the set of secondary structures found in the
proteomes. Yet, there also exist intriguing structures and motifs that are underrepresented in natural
biopolymeric systems. One example is the polyproline II helix, which is usually considered to have a
polar character and therefore does not form membrane spanning sections of membrane proteins. In our
work, we have introduced specially designed polyproline II helices into the hydrophobic membrane
milieu and used 19F NMR to monitor the helix alignment in oriented lipid bilayers. Our results show that
these artificial hydrophobic peptides can adopt several different alignment states. If the helix is shorter
than the thickness of the hydrophobic core of the membrane, it is submerged into the bilayer with its
long axis parallel to the membrane plane. The polyproline helix adopts a transmembrane alignment
when its length exceeds the bilayer thickness. If the peptide length roughly matches the lipid thickness,
a coexistence of both states is observed. We thus show that the lipid thickness plays a determining role in
the occurrence of a transmembrane polyproline II helix. We also found that the adaptation of polyproline II
helices to hydrophobic mismatch is in some notable aspects different from a-helices. Finally, our results
prove that the polyproline II helix is a competent structure for the construction of transmembrane peptide
segments, despite the fact that no such motif has ever been reported in natural systems.
Introduction
Living nature operates with a few types of biopolymeric scaf-
folds involved in major biochemical processes. The main two
are nucleic acid and polypeptide types, ubiquitous for all living
systems. The ability to interact with lipid membranes is one of
the key chemical differences between these two biopolymeric
‘‘worlds’’. Both a lack of hydrophobic elements and high
negative charge render nucleic acids unable to transverse
membranes.1 Conversely, proteins possess all necessary features
to insert into lipid bilayers, thereby forming functional membrane
protein scaffolds. The introduction of proteins and their anchoring
within lipid bilayers were a critical step in the origin of life, which
is based on the utilization of compartments and gradients. The
interactions of proteins with the membrane are very diverse,
being associated with the presence of hydrophobic (Leu, Ile,
Val),2,3 anchoring (Trp, Lys),4 and other amino acid residues
that are, e.g., in contact with the polar head group region (Arg,
Lys),5,6 or forming intraprotein interfaces (Gly, Ala, Ser, etc.).7
Virtually every encoded amino acid can be utilized for the
construction of membrane proteins, to either interact with the
lipid medium or form the interior of an integral membrane
protein with desired function and specificity.8
However, when considering the secondary structure elements
that carry the side-chain functions, this natural versatility
vanishes. Typically, when traversing the membrane with hydro-
phobic transmembrane (TM) elements, nature becomes extremely
conservative, utilizing only two standard secondary structures to
accomplish this task. The vast majority of integral TM proteins are
constructed from a-helices that are often regarded simply as ‘‘TM
helices’’; another class of membrane proteins consists of b-barrel
structures (only occur in special types of membranes).9 In the
aqueousmedium, nature operates with a much larger repertoire of
secondary structures, but only a few are present in membrane
embedded proteins. Among these structures excluded from the
membrane, themost widespread is the polyproline-II (PII) helix, also
regarded as a ‘‘semi-extended’’ helix (Fig. 1A).10,11 Interestingly, in
the history of life evolution, the PII helix was present at the very
beginning of protein biosynthesis, before the a-helix became the
dominant protein fold.12 It is therefore quite surprising that this
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structural element was not utilized to formmembrane spanning
segments. One potential explanation for this fact could be that
the structure itself is too hydrophilic, thus incompatible with the
hydrophobic environment of a lipid bilayer. Indeed, in biochemical
settings, the PII helix is present in polar environments: in globular
proteins,13 in solvated exposed peptide stretches,14 as well as in
intrinsically disordered proteins and protein fragments lacking
persistent structure.15,16 If the PII helix acts as an intrinsically polar
structure in nature, does this mean that it can only be polar?
The answer is ‘no’, and the apparent hydrophilicity of PII
helices can actually be overcome by means of peptide chemistry,
when utilizing a specific amino acid composition. For example,
it is possible to substantially reduce the polarity of the PII helix,
simply by replacing the backbone with a tertiary amide, thereby
eliminating the polar NH-bonds. In this context, oligoproline
peptides are especially convenient scaffolds, because proline
naturally forms a tertiary amide bond. However, the direct use
of oligoproline in a nonpolar environment is precluded due to an
insufficient hydrophobicity of the prolyl side-chains (Fig. 1B)17,18 as
well as the weak relative stability of the PII helix.
19,20
We have taken all these considerations into account and
designed an oligoproline scaffold based on the proline analogue
(2S,3aS,7aS)-octahydroindole-2-carboxylic acid (Oic). This amino
acid is hydrophobic (Fig. 1B), and at the same time it features
stronger backbone-stabilizing contacts than the parent proline
structure.21 The PII helix formed by oligo-Oic sequences turned
out to be both stable and highly lipophilic, and it maintains the
desired fold when dissolved in nonpolar solvents such as
alkanes.18,22 Based on this peptide scaffold, we have recently
reported an oligo-Oic peptide with a TM alignment in model
lipid bilayers.23 We have thus proven that a TM PII helix is a
realistic option. Therefore, it might be quite astonishing that
such a motif has never been discovered in natural proteomes.
This very fact has numerous implications for membrane bio-
physics, protein engineering, and understanding the evolution
of life. Indeed, if nature operates transmembrane peptides and
PII helices, why does it not operate transmembrane PII helices?
To answer this rather general question, we need to collect
much better understanding on the actual behaviour of the helix
in the membrane. For example, our pioneering observation of a
TM PII helix still does not explain which factors in the peptide
architecture and/or the lipid membrane determine the trans-
membrane alignment. To further investigate this first TM PII
helix, we have designed here an experimental study with the
aim to test for the occurrence of the TM state under various
peptide/lipid conditions. In this way, we intend to explain
which elements of the peptide structure and of the lipid bilayer
result in a TM alignment, and which do not. We envisage that
these explanations will help in utilizing the TM PII motif in
further biochemical settings. At the same time, we expect that
the trends observed here with the model PII helix may provide a
unique insight into the general aspects of the interaction of a
folded peptide body with the lipid environment.
The PII helix is a rare example of a natural peptide structure,
which is not at all based on hydrogen bonding. One of the
notable features of this new TM PII helix is its simple geometric
arrangement, with 3.0 residues per turn and 9 Å per turn
(Fig. 1A).21,24,25 Thereby, an extended TM PII helix requires only
half as many residues to traverse the membrane as compared to
a ‘‘classical’’ TM a-helix. At the same time, it places the residues
directly above one other with a more compact 9 Å periodicity
(i2 i + 3), compared to the more extended 10.5 Å stacking of
residues in an a-helix (i2 i + 7, Fig. 1A). Thus, a TM PII helix
will offer a versatile and useful tool for peptide/protein engineering,
when its membrane behaviour is properly understood.
Experimental section
Preparation of the peptides
The starting nonameric peptide 1 with a CF3-label in the middle
position and C6-based positive charge linkers was prepared as
described.23 Next, we synthesized a series of peptides with
variations in each component of the peptide structure: we
varied the position of the 19F NMR label (peptides 2, 3), the
presence of the terminal charges (peptides 4–6), the length of
the charge linkers (peptides 7, 8), and the overall length of the
peptide (peptides 9–13). The sequences are summarized in
Table 1.
The synthesis of oligomeric-Oic peptides has specific
peculiarities. We found previously that oligo-Oic sequences longer
than 5 amino acid residues complicate the solid-phase peptide
synthesis due to their limited solubility in DMF.18 Therefore, we
applied the following two strategies for the peptide synthesis. In
the first approach (Scheme 1A), we synthesized peptide fragments
not longer than five amino acids on resin with normal resin
loading and using N,N-dimethylformamide (DMF) as a solvent.
The peptides with Boc-groups at the N-termini were cleaved from
Fig. 1 (A) The polyproline-II (PII) helix, compared to an a-helix. (B) Experimental
logP scale determined for methyl esters of N-acetyl amino acids.18 Proline
and its derivatives are highlighted in red.
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the resin in a hexafluoro-2-propanol/dichloromethane cocktail,
which keeps the Boc-group intact.26 The fragment meant to be
at the C-terminus was either coupled with the Cbz-protected
hexamethylenediamine (for C6 charge linkers) or esterified with
2,2-difluorodiazoethane (for other size linkers).27,28
Then, we removed the Boc-group from the C-terminal fragment
peptides, and these were coupled with the corresponding N-terminal
fragment peptides, yielding full-length peptides. The N-terminal Boc-
and C-terminal Cbz-protection groups were removed simultaneously
to give target peptides 2, 3, and 11 (Scheme 1C). For the synthesis of
7 and 8, the peptides with 2,2-difluoroethyl esters at the C-terminus
were mixed with liquid diamines, trimethylenediamine (at room
temperature) and octamethylenediamine (at elevated temperature),
respectively. The final peptides 7 and 8 were obtained after the
N-terminal Boc-group was removed.
In another strategy, the full-length peptides were prepared
on-resin with low-loading. A DMF-dichloromethane mixture
was used as the solvent for coupling all amino acids beyond
the 10th residue (Scheme 1B). The peptides were cleaved off the
resin, the C-terminal charge linker was installed in solution, and
the simultaneous removal of the protection groups yielded target
peptides 9–13 (Scheme 1C). The peptides with removed charges
(4–6) were synthesized analogously, as shown in Scheme 1D.
Identity and purity of final peptides were confirmed by mass-
spectra (ESI-Orbitrap), liquid chromatography (UV detection at
220 nm), and 1H NMR (CD3OD, 600 MHz) spectra (see ESI†).
Solid state NMR
Lipids. 1,2-Dilauroyl-sn-glycero-3-phosphocholine (12:0/12:0
PC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (14:0/14:0 PC),
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (16:0/18:1 PC),
1,2-dioleoyl-sn-glycero-3-phosphocholine (18:1/18:1 PC), 1,2-dieico-
senoyl-sn-glycero-3-phosphocholine (20:1/20:1 PC), 1,2-dierucoyl-sn-
glycero-3-phosphocholine (22:1/22:1 PC), and 1-oleoyl-2-hydroxy-sn-
glycero-3-phosphocholine (18:1 lyso-PC). The bilayer thickness was
interpreted using the literature data.29–31
Sample preparation. The peptides were reconstituted in
lipids at a 1/40 peptide-to-lipid ratio unless stated otherwise.
Samples were prepared as follows. Peptide (0.42–0.66 mg) and
lipid (7.8–8.0 mg) were mixed at a 1/40 molar ratio to give an
8.4 mg final weight. The mixture was dissolved in chloroform
(0.25–0.4 ml), and the resulting clear solution was spread evenly
over 14 rectangular cover glass plates (7.5  12 mm). The
samples were dried first in air and subsequently under vacuum.
The plates were stacked, the last plate being covered by
an empty plate. The lipid bilayers were hydrated by keeping
the stack in a humid chamber containing a vial filled with
saturated potassium sulfate solution at 48 1C for 17–22 hours.
The samples were wrapped in several layers of fluorine-free
plastic foil to prevent drying. They were kept at room temperature
prior to the NMR measurements.
Spectra acquisition. Solid-state NMR spectra were acquired
at 35 1C (standard methanol calibration), which corresponds to
the fluid phase for all examined lipids.32 The samples were
placed in a low E flat coil probe,33 such that the bilayer normal
was parallel to the magnetic field B0.
1H NMR spectra were
acquired first for referencing, with the downfield shoulder line
taken as water (4.7 ppm), which was then used to calibrate the
31P and 19F NMR spectra assuming ratios for the 31P/1H or
19F/1H resonance frequencies (zero ppm) of x = 0.404807210
and 0.940939011, respectively.
To assess the quality of lipid alignment for each sample,
31P{1H} HMR spectra were acquired at 202.5 MHz using a Hahn
echo pulse sequence with 1H decoupling during acquisition
(spinal64, 17 kHz). Parameters were as follows: 90 degree pulse
of 5 ms at 95 W, echo delay of 20 ms, dwell time of 1 ms, time
domain of 16 384, recycling delay of 3 s, 256 scans, and the
transmitter frequency was set around 0 ppm. The spectra were
processed using exponential line broadening with a Lorentzian
parameter of 100 Hz. A 5th degree polynomial function was
applied for baseline correction of the frequency domain spectra.
Unless stated otherwise, the spectra demonstrated 80% or
higher alignment of the lipid according to integration over the
31P signal.
The 19F{1H} NMR spectra were acquired at 471 MHz, using a
single 90-degree pulse experiment with 1H decoupling during
acquisition (spinal64, 12.5 kHz). Parameters were as follows:
90 degree pulse of 2.5 ms at 180W, dwell time of 1 ms, time domain
of 4096, recycling delay of 2 s, 2048 or more scans, and the
transmitter frequency was set around 75 ppm. For processing,
500 Hz Lorentzian line broadening and 5th degree polynomial
baseline correction were applied to the spectra.
Table 1 Peptides analysed in this study
# PII length, residues Terminal charge linkers Peptide sequence
1 9 C6 H3N
+(CH2)5CO-(Oic4-TfmPro-Oic4)-NH(CH2)6N
+H3, 2Cl

2 9 C6 H3N
+(CH2)5CO-(Oic3-TfmPro-Oic5)-NH(CH2)6N
+H3, 2Cl

3 9 C6 H3N
+(CH2)5CO-(Oic5-TfmPro-Oic3)-NH(CH2)6N
+H3, 2Cl

4 9 none H3CCO-(Oic4-TfmPro-Oic4)-OCH3
5 9 C6; none H3N
+(CH2)5CO-(Oic4-TfmPro-Oic4)-OCH3, Cl

6 9 none; C6 H3CCO-(Oic4-TfmPro-Oic4)-NH(CH2)6N
+H3, Cl

7 9 C3 H3N
+(CH2)2CO-(Oic4-TfmPro-Oic4)-NH(CH2)3N
+H3, 2Cl

8 9 C8 H3N
+(CH2)7CO-(Oic4-TfmPro-Oic4)-NH(CH2)8N
+H3, 2Cl

9 10 C6 H3N
+(CH2)5CO-(Oic5-TfmPro-Oic4)-NH(CH2)6N
+H3, 2Cl

10 10 C6 H3N
+(CH2)5CO-(Oic4-TfmPro-Oic5)-NH(CH2)6N
+H3, 2Cl

11 11 C6 H3N
+(CH2)5CO-(Oic5-TfmPro-Oic5)-NH(CH2)6N
+H3, 2Cl

12 12 C6 H3N
+(CH2)5CO-(Oic7-TfmPro-Oic4)-NH(CH2)6N
+H3, 2Cl

13 12 C6 H3N
+(CH2)5CO-(Oic4-TfmPro-Oic7)-NH(CH2)6N
+H3, 2Cl

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Results
Design of the peptides
The peptides were designed according to the following con-
siderations. First, the peptide sequence was based on an
oligomeric Oic structure to enable the desired selectivity for a
hydrophobic environment (Fig. 2A). Sufficient hydrophobicity
of the core peptides can be inferred from the fact that oligo-Oic
peptides with 6 or more residues are not soluble in water, but
they are soluble in hexane as well as other organic solvents,
such as dichloromethane or chloroform, which are typical
solvents for lipids.18 Second, the length of the sequence should
Scheme 1 Synthesis of the target peptides 1–13.
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be close to the thickness of the hydrophobic core of the model
lipid bilayers. For example, a nonameric peptide Oic9 makes
3 turns of a PII helix, resulting in approx. 9  3 Å = 27 Å effective
length, which should perfectly match the hydrophobic thick-
ness reported for 14:0/14:0 PC (26 Å at 30 1C, Fig. 2B).31 Third,
we included terminal positive charges, with the aim to anchor
the peptide ends in the head group section of the lipid bilayer.
We introduced these charges using chemical rather than bio-
chemical building blocks; this means that the positive charges
were not entire amino acid residues (such as Lys or Arg), but
they were simple ammonium groups on minimalistic C6 linkers,
attached via amide bonds at each of the two termini (Fig. 2C). The
purpose of the C6 linkers was to avoid any deleterious impact of
the terminal charge on the stability of the PII conformation.
34,35
Finally, the fourth construction element is an orientation-dependent
NMR label. One of the Oic residues was replaced by (2S,4S)-
trifluoromethylproline (TfmPro),36 a hydrophobic proline analogue
(Fig. 1B). This amino acid bears a CF3-group, which is a highly
sensitive 19F NMR reporter group that reflects the backbone align-
ment in an anisotropic environment (Fig. 2D).37,38
We then carried out the orientational analyses on the peptides
embedded in lipid bilayers, in samples that were macroscopically
oriented on glass plates. In these fully hydrated samples, the
membranes spontaneously form a lamellar phase, with all bilayers
arranged parallel to the surface of the glass plates. They are placed
in the NMR probe such that the bilayer normal is aligned parallel to
the external magnetic field B0.
39 In this experimental setting, any
defined peptide orientation in the lamellar lipid bilayer should
result in a characteristic 19F NMR signal. The anisotropic signature
of the CF3-group is a triplet, due to the dipolar coupling between the
three equivalent fluorine nuclei. Both the shift of the triplet position
from the isotropic diso position (chemical shift anisotropy, dCSA) and
the observed distance between the triplet components (splitting
value, D) have the same dependence on the CF3-group orientation
with respect to B0, angle y, as expressed in eqn (1) and (2).
40
The splitting value is considered to be the most sensitive
and reliable quantitative parameter, because it does not require
referencing of any kind (external or internal), while dCSA (position of
the resonance) unambiguously reveals the sign of the splitting.
dCSA ¼ dmaxSmol3 cos
2 y 1
2
(1)
D ¼ DmaxSmol3 cos
2 y 1
2
(2)
Here, dmax and Dmax are the maximal values that define the full
spectral width. For an axially rotating aliphatic CF3-group, these
values are 52 ppm and 16 kHz, respectively.40 Smol is a molecular
order parameter, which reflects the mobility of the helix that is
assumed to wobble as a rigid body. For an immobilized molecule,
Fig. 2 Design of the study. The TM PII peptide should be based on a hydrophobic oligoproline scaffold (A) with a sufficient length to span the membrane
(B), with terminal charge linkers to anchor on the polar sides of the membrane (C), and with a CF3-label as an orientation probe for a
19F NMR based
method (D).
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Smol equals 1.0, whereas for an isotropically averaged helix (e.g. in
homogenous solution), this value becomes zero.
The peptide states
For peptide 1, with an assumed hydrophobic length of about
27 Å, we have previously observed a single triplet signal of the
CF3-group in short lipid bilayers (12:0/12:0 PC, B22 Å), which
defines a unique helix alignment, while two peptide populations
were observed in longer chain lipid bilayers (16:0/18:1 PC,
B29 Å).23 Because the former signal is consistent with an
upright TM orientation of the helix, while the latter two signals
are not, we concluded that the TM orientation is adopted only in
the short-chain lipid. We thus speculated that in the long-chain
lipid, the helix would be submerged within the bilayer such that
both charged termini reside on the same face of the membrane.
As the helix axis lies essentially parallel to the bilayer plane in
this state (which we had described as a hammock-like state),
we will now refer to it as a ‘‘submerged state’’ (SM-state). An
intermediate situation was found in 14:0/14:0 PC (B26 Å),
where we had observed the simultaneous occurrence of all three
sets of splittings in the same spectrum.
Clearly, a single anisotropic label in 1 is not enough to
resolve the full 3D orientation of the peptide in the membrane, nor
can any alternative orientations be ruled out that are compatible
with the single data point. Thus, our initial conclusions regarding
the peptide states need to be confirmed with amore comprehensive
set of data. For this reason, here, we prepared isomeric peptides 2
and 3 with TfmPro shifted one position down or up in the helix,
respectively. As a result, the relative orientations of the CF3-groups
with respect to the helical axis differ by about 1201 between the
isomeric peptides.
Our experiments demonstrate that in the short-chain lipid,
the splitting remains nearly the same for all three peptides,
5.8, 6.8 and 6.7 kHz for 2, 1 and 3, respectively (Fig. 3).
This very straightforward observation already gives a clear
indication that in all cases, the helix axis is aligned parallel
with respect to B0, indicating a TM state of these peptides. In
contrast, in the longer chain lipid, the major splitting showed
alternating values of +4.0, 3.8 and +6.8 kHz, for 2, 1 and 3,
respectively. These data are fully consistent with the helix axis
being orthogonal to B0, thus the peptide being aligned in the
SM state. We drew out the SM state based on the assumption
that the helix remains in the hydrophobic core, and does not
come out into polar sections of the lipid bilayer. The spectra in
14:0/14:0 PC demonstrate a co-existence of states for all three
peptides, indicating that the TM2 SM transition is slow on
the NMR time scale.
Next, we analyzed the obtained data in terms of peptide
orientation, as defined by two angles t and r, plus the mole-
cular order parameter Smol that quantifies mobility. In this
description, the tilt angle (t) gives the tilt of the helical axis with
respect to bilayer normal. We define the azimuthal rotation
angle (r) as the rotational position around the helix of the
Ca-carbon atom in the 5th residue (Fig. 4A).‡ In our analysis,
we combined the orientations of the three CF3-labels from
separate experiments to calculate the orientation of the helix
based on the following assumptions: (i) the helix alignment is
not influenced by the position of the label (TfmPro); (ii) the
sterically bulky CF3-group in the TfmPro residues adopts an
equatorial conformation;36 (iii) the maximal dipolar splitting
value Dmax is the same as for other CF3-labeled amino acids
(16 kHz).36,40 To obtain the helix orientation that best agrees
with the experimental data, we systematically calculated the
expected dipolar splitting for all possible combinations of t,
r and Smol. The agreement between the calculated splitting
(Dcalc,i) and measured splitting (Dexp,i) was quantified by a root
of mean square deviation (rmsd) according to eqn (3):
rmsd ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1
N
XN
i¼1
Dexp;i  Dcalc;i
 2
vuut (3)
Fig. 3 Examination of the membrane alignment of isomeric nonanpeptides carrying a 19F NMR label in different positions.
‡ The r angle can be visualized as the angle needed to turn the helix around its
axis until the tilt vector points towards the 5th Ca-carbon. The tilt vector is
orthogonal to the helix axis and points to the direction in which the C-terminus is
slanted, see Fig. 4A for graphical representation.
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To find the best-fit solution, t and r were varied from 01 to
1801 in steps of 11, and Smol was varied from 0 to 1.0 in steps of
0.1. The results presented in Fig. 4B clearly illustrate a TM
alignment in the short-chain lipid with a small tilt angle of t =
61 (Table 2). Conversely, in the long-chain lipid, the solution
was a nearly perpendicular tilt angle with t = 871, which is fully
consistent with our suggestion of a SM state. We thus con-
firmed that the peptide exists in an equilibrium between the
proposed states, where the bilayer thickness has a decisive
influence on the alignment of the peptide.
The terminal groups
We then decided to examine the influence of the terminal
charges on the helix alignment. We first compared the spectra
of the peptides with two (1) and without any (4) charges, and
with the peptides bearing a single charge on either terminus
(5 and 6). The spectra of the short-chain lipid demonstrate that
all peptides adopt the TM alignment (Fig. 5). However, the TM
alignment was complete only for the peptide with two terminal
anchoring charges (1), while another additional state was
present for the other peptides of this series (4–6). In all cases,
the TM alignment was lost in the long-chain lipid, as expected.
Interestingly, in the long-chain lipid, the peptide without
C-terminal charge (5) exhibited only one triplet (+2.3 kHz),
whereas sets of splittings were observed for both peptides with
a C-terminal charge (1 and 6). These results suggest that the
rotational state of the peptide in the SM state relies on the
orientation of the charge linkers relative to the peptide body.
Furthermore, the co-existence of two triplets in the expected SM
state may originate from rotational hopping of the terminal
amide, which is a slow process on the NMR time scale
(Scheme 2). We previously identified that the terminal amide
rotation is the major source of the alternative conformations in
oligo-Oic peptides.21 Both amides with the C- and N-terminus
may lead to multiple conformations, which will necessarily
result in different local orientations of the charge linkers with
respect to each other, thereby generating different orientations
of the peptide backbone in the lipid bilayer. Notably, different
orientations of the charge linkers only generated visible differ-
ences in the SM, but not TM state where only one triplet was
observed (6.8 kHz). Indeed, in the TM state, the helix stands
upright, hence mutual orientation of the linkers becomes
unimportant for peptide alignment.
As a next step, we examined the importance of the length of
the charge linkers. At this point, we hypothesized that the size
of the charge linkers may influence the depth of the hydro-
phobic peptide placement in the lipid hydrophobic core, when
the peptide adopts the SM state. Following this assumption, the
charge linker size may influence the stability of the SM state,
thereby affecting the TM2 SM equilibrium.
To this end, we measured peptides with C3 (7) and C8 (8)
linkers at both termini of the nonameric peptide. According
to our expectations, shorter charge linkers would disfavour the
SM state, because they would pull the peptide out from the
Fig. 4 Tilt-rotation presentation of the helix alignment in lipid bilayers.
(A) Definitions of the coordinate angles. (B) Results obtained from the
combined data on peptides 1, 2 and 3.
Table 2 Helical orientation for the PII helix alignment, as derived from the
19F NMR data from nonameric peptides 1, 2 and 3
Lipid t r Smol rmsd, kHz
12:0/12:0 PC 6 84 0.85 0.13
16:0/18:1 PC 87 88 0.75 1.09
Fig. 5 Dependence of the nonameric peptide alignment on the presence
and position of the terminal charges.
Scheme 2 Terminal rotation of the amide moieties generates different
alignments of the charge linkers with respect to each other.
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hydrophobic core (the pulling-out effect). The experimental 19F
NMR spectra confirmed our expectations (Fig. 6). We found
that in 14:0/14:0 PC, where the SM and TM states co-exist for
the C6 and C8 linkers, shortening of the linker to C3 eliminated
the SM state almost entirely. Nonetheless, a shorter size of the
linker did not eliminate the SM state completely: in the longer
chain lipid, 16:0/18:1 PC, the spectra were still fully dominated
by the SM state resonances for all three peptides. Overall, we
conclude that the charge linker size is only of secondary
importance, while the TM 2 SM state equilibrium depends
primarily on the lipid thickness. In addition, the pulling-out
effect of the terminal charges provides indirect proof for the
localization of the peptide in the hydrophobic core, when the
helix adopts the SM state.
The length of the helix
To explore the influence of the length of the helix on its
behaviour in the membrane, we extended the length of the
helix by adding an Oic residue to peptide 1 at the N-terminus
(9), the C-terminus (10), or at both ends (11), or otherwise by
adding one helical turn at the N- (12) or C-terminus (13).
According to the basic architecture of the PII helix, each
additional Oic residue adds 3 Å to the hydrophobic length of
the peptide. As a result, we expected that the TM2 SM peptide
re-alignment will shift to longer chain lipids.
We first examined the undecameric peptide 11 in a series of
lipids (Fig. 7). In the short-chain lipids, the signal appeared as a
triplet with a splitting of 6.8 kHz, which is identical to the
value observed in the TM alignment of the nonameric peptide.§
In the long-chain lipids, the signal changed to a triplet with a
distinctly different splitting of +8.1 kHz. Hence, a re-alignment
of the peptide occurred in the lipids 16:0/18:1 PC and 18:1/18:1
PC. Thus, we confirmed our original assumption that for longer
peptides, the TM2 SM peptide transition is shifted to longer
chain lipids.
Interestingly, the value of the dipolar splitting in the TM
state was the same in all lipids where this state was observed
(E6.8 kHz). This finding suggests that the tilt of the PII helix
does not change from the essentially upright orientation,
despite the distinctly different hydrophobic thicknesses of the
corresponding lipids, ranging from 22 to about 29 Å. Since the
length of the hydrophobic PII helix in 11 is about 33 Å, the TM
alignment of this peptide in the shortest lipids should be
accompanied by a drastic mismatch between the long hydro-
phobic peptide and thin hydrophobic membrane core, known
as ‘‘positive mismatch’’. Indeed, we found indications that the
lipid environment undergoes some adaptation to compensate
for this mismatch. Namely, both of the shortest lipids in the
series, 12:0/12:0 PC and 14:0/14:0 PC, showed a sizable fraction
of non-oriented lipids in their 31P NMR spectra, indicating a
notable loss of lipid orientation in the presence of peptide 11
(Fig. 7, right panel). The 19F NMR spectra of these samples also
exhibited unusually broadened resonances (Fig. 7, left panel),
thereby indicating that the sample orientation is severely
perturbed by the presence of the peptide.
We further analysed the lineshapes of both 19F and 31P NMR
spectra of the sample containing peptide 11 by fitting them
with a distribution of orientations (see ESI†). No further
orientation states besides the TM and SM states were required
to explain the 19F NMR spectra. The broadening effects
observed in the 31P and 19F NMR spectra in short-chain lipids
were both caused by a similar amount of a badly/non-oriented
fraction, visible in the 19F spectra as a shoulder near 70 ppm,
and in the 31P spectra as a powder lineshape with a maximum
near 15 ppm. This behaviour was concentration dependent.
When the peptide was diluted from a peptide-to-lipid ratio of
1/40 down to 1/200, all these special features were gone, and
both the 31P and 19F NMR spectra appeared sharp like the other
samples (bottom spectra in Fig. 7). We can thus conclude that
the adaptation to positive hydrophobic mismatch does not
include any tilting of the TM PII helix in contrast to what has
been reported for a-helices.41–44 We thus conclude that positive
mismatch shows up as a perturbance of the lamellar lipid
Fig. 6 Influence of the terminal groups on the alignment of the nonameric peptide in membranes.
§ We note at this point that for a peptide in an upright orientation, the splitting
value should remain the same regardless of the helical length.
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bilayers. We note at this point that we did not observe
additional 31P NMR signals near 0 ppm or to the right of the
signal at B30 ppm, which would be indicative of non-lamellar
phases such as inverted micelles or hexagonal phases. We can
hence exclude that the peptide induces severe structural
changes of the lipid bilayer.
These conclusions obtained from the examination of the
undecameric peptide 11 agree well with the results from the
remaining series of PII peptides. For the decameric peptides (9
and 10), we observed a transition between the TM and SM state
between 14:0/14:0 PC (prevalence of TM) and 16:0/18:1 PC
(prevalence of SM, Fig. 8). For dodecapeptides 12 and 13, the
re-alignment was shifted to longer chain lengths: a co-existence
of TM and SM was observed in 20:1/20:1 PC (Fig. 9).¶ The
phenomena associated with positive mismatch (resonance
broadening, loss of the oriented part) were observed in short-
chain lipids, and the splitting of the TM alignment was the
same as for the other peptides in this series, 9–11. This fact
again confirms our previous conclusion that the peptide does
not tilt under positive mismatch, instead it seems that the
lipids that adapt to the upright-standing TM helix.
Presence of lyso-lipids
Finally, we examined the influence of lyso-lipids on the TM2 SM
equilibrium. It is well known that addition of lyso lipids reduces
the lateral pressure in the hydrophobic core of the lamellar bilayer.
For amphipathic a-helices and b-barrel proteins, it has been
demonstrated that lyso-lipids can significantly promote the TM
orientation by modulating the membrane curvature, compared to
their surface-bound states.45,46 Could lyso-lipids promote the TM
alignment of the PII helical system as well?
To address this question, we took peptide 11 and examined
its 19F NMR spectra in membranes upon the addition of lyso-
lipids, judging the TM2 SM equilibrium by integration of the
respective signals of the TM and SM states (Fig. 10). Our results
demonstrate that a lyso-lipid content of up to 40 molar% does
not change the ratio between the two states. These results fully
Fig. 7 Re-alignment of the undecameric peptide (11) in a series of lipids.
Fig. 8 Re-alignment of the decameric peptides (9 and 10) in a series of
lipids.
Fig. 9 Re-alignment of the dodecameric peptides (12 and 13) in a series
of lipids.
¶ Here, we would like to note that the 19F NMR splittings in the SM state of
peptides 1, 12 (three residues added at the N-terminal section), and 13 (three
residues added at the C-terminal section) are the same. This observation directly
confirms the 3.0 residue/turn periodicity of the PII helix in the SM state(s) of the
peptides.
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agree with our earlier observations of peptide 1 in lipid bilayers,
where the addition of about 1/3 molar lyso-lipid failed to
promote the TM state.23 The absence of the influence from
the lyso-lipid content can be explained by the fact that our PII
peptides reside in the hydrophobic lipid core in both states, TM
and SM. Thus, lowering of the pressure in the hydrophobic core
relative to the lipid head group region does not show an effect
on the equilibrium between these states.
Discussion
Lipid bilayers have a distinct lateral pressure profile, depending
on the spontaneous curvature of the constituent lipids.47 The
relative lateral pressure in the head group region and the
hydrophobic core exerts a significant effect on the molecules
immersed in it. For example, in well-balanced lamellar bilayers
like the ones we used here (spontaneous curvature close to
zero), a rigid cylindrical body would have a tendency to orient
parallel to the bilayer normal, as can be exemplified by cholesterol
molecules (Fig. 11).48–51 Hydrophobic helical peptides usually
adopt the same transmembrane alignment, with a-helical oligo-
Leu52 or oligo-AlaLeu (mainly, WALP and KALP peptides)53 as
typical models.54 Other interesting but more complex examples
include transmembrane assemblies such as the oligomeric ala-
methicin pore55–57 as well as the dimeric gramicidin A pore.58–60
In our study, we examined the alignment behaviour of a
hydrophobic PII helical structure. Considering an oligo-Oic core
peptide as a rigid body with similar geometric requirements to
other common hydrophobic objects (Fig. 11), we would expect
that this model peptide should indeed adopt a transmembrane
alignment in lipid bilayers.
To prove this hypothesis, we first constructed a nonameric
peptide with an estimated effective length of about 27 Å, and
examined its alignment in lipid bilayers. The incorporation of a
single NMR label (CF3-group) at three different positions on the
helix allowed us to probe all three faces of the helix (peptides 1,
2, 3). Our results unambiguously prove that the peptide aligns
parallel to the membrane normal in short-chain lipids (22 Å
hydrophobic thickness). In contrast, in long-chain lipids (29 Å),
it aligns preferably perpendicular to the bilayer normal, and in
the matching lipid (26 Å), we observed a co-existence of states
in our NMR spectra (Fig. 3, 4 and Table 2). These observations
are consistent with our proposed interpretation that the peptide
can adopt both an upright transmembrane (TM) alignment and
a state in which the helix is submerged (SM) horizontally
beneath the head group region of the lipid.
The finding that a negative mismatch (bilayer thickness
greater than the peptide length) results in a SM state was rather
unexpected. In the case of amphipathic membrane-associated
peptides, the helix is usually oriented perpendicular to the
bilayer normal (often called the ‘surface’ state).61 However, in
the case of hydrophobic a-helices, there exist only a very few
examples where an alignment parallel to the bilayer surface was
suggested under conditions of negative mismatch.62–65 Generally,
for hydrophobic a-helical peptides, a TM orientation can usually be
concluded already from the simple observation that the peptide
resides in the lipid hydrophobic core (for example, using Trp
fluorescence assay).66
With our PII helical model, we show that the placement of a
sufficiently hydrophobic helix into the hydrophobic core does
not necessarily imply a TM state, but could also be compatible
with a SM state. Interestingly, a similar two-state coexistence is
known for bolalipids, where the corresponding states are referred
to as a spanning (analogous to TM) and looping (analogous to
SM) state.67 Transmembrane peptides with anchoring charges
are similar to bolalipids, with the difference that the hydrophobic
part is not really flexible in peptides.
We consider two possible explanations for the unexpected
occurrence of the SM state in our PII model peptide. The first
explanation is that the peptide has a lower density compared to
an a-helix (see Fig. 11), therefore it is less influenced by the
membrane lateral pressure when oriented perpendicular to the
lipid chains in the SM state. Another explanation is that the
anchoring linkers are much thinner and more flexible than a
contiguous a-helix. Indeed, a-helical TM segments are usually
decorated with anchoring residues, which tend to have a direct
Fig. 10 Spectra of the undecameric peptide 11 in 18:1/18:1 PC show
absence of systematic dependence from the presence of 18:1 lyso-PC.
Fig. 11 Dimensions of some relevant hydrophobic rigid bodies.
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influence on the peptide orientational behaviour, dynamics
and membrane interactions. For a-helical model peptides, the
terminal anchoring regions are rather complex, involving several
amino acid residues that typically include Lys, Trp, or other
aromatic residues (WALP, KALP and others).53,54,62,68,69 Conversely,
in our model peptides, the anchoring linkers are rather minimalis-
tic, with a single ammonium group attached flexibly to each end of
the helix. This is why results on a-helical and PII TMpeptides are not
directly comparable. Future studies should reveal whether more
complex terminal anchors will substantially favour the TM
alignment of the PII helical construct.
In our current examination of peptides with different lengths
(1, 9–13), we have confirmed the tendencies observed for the
first nonameric peptide, and the summary on peptide align-
ment is shown in Fig. 12. Considering the PII architecture with
3 Å length increment per residue, our peptide series was designed
to probe lengths between 27 and 36 Å. In all instances, we observed
the TM state in short-chain lipid(s), while an unusual submerged
state (SM) prevailed in long chain lipids (Fig. 7–9).
These results show that the SM2 TM transition is a general
phenomenon. The co-existence of states occurred in certain
lipids with intermediate thickness. This transition was shifted
towards longer lipids for longer peptides: from 14:0/14:0 PC
(26 Å) for nonameric peptide (1, 27 Å), to 20:1/20:1 PC (32 Å) for
dodecameric peptides (12 and 13, 36 Å).
Furthermore, we found that the orientation of the CF3-label
was the same for all peptides in the TM state, even when there was
significant positive mismatch between a long peptide embedded in
a thin membrane. This is an indication that the peptide remains
upright in the TM state, and does not tilt to adapt to the hydro-
phobic mismatch, in contrast to our preliminary suggestion
earlier.23 This finding contrasts the typical behaviour of a-helical
peptides, for which changes in peptide tilt and dynamics are usually
observed in the case of a positive mismatch.41–44,53,54 Furthermore,
the loss of the peptide orientation in concentrated samples (as
observed in both the 31P and 19F NMR spectra) indicates adaptation
of the lipid to the essentially upright standing helix (Fig. 12, right
panel).62 Nonetheless, in this study, we did not collect enough data
to elucidate the lipid adaptation mechanism with full confidence.
Conclusions
With this comprehensive set of data, we fully confirmed
our preliminary report on the existence of a TM PII helix.
23
We found that this TM state of the helix exists in equilibrium
with a submerged state of the peptide. The ratio between the
helix length and the hydrophobic membrane thickness plays a
pivotal role in the peptide alignment.
The novel PII TM helix is an artificial peptide motif, and it is
the first reported transmembrane peptide where the stability is
not based on hydrogen bonding. Being more hydrophobic than
natural proline, the chemically modified Oic analogue allowed
us to construct such a new motif de novo, which has never been
found in the proteome.
We believe that this design route will help to rationalize the
chemical limitations of natural protein architectures. Further-
more, these novel peptide frameworks could contribute to a
bottom-up design of artificial biological diversity, such as
synthetic life, with an alternative chemistry. We recently speculated
that from a strategical perspective, a proteome-wide exchange of the
underlying secondary structure can give rise to a completely new
biological World.12b After reporting a hydrophobic PII helix, our
recent study on collagen mimicking peptides suggests a possibility
for oligomeric PII assemblies in hydrophobic media.
70 Therefore,
our discovery of the TMPII helix opens up an avenue for engineering
entirely new types of de novo membrane-associated peptide
structures, not present in nature but deliberately constructed
under laboratory conditions.
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